NR293 Pharmacology For Nursing Practice And Medication Teach ✓ Solved

NR293 Pharmacology for Nursing Practice Medication Teaching Plan

The purpose of this assignment is for the student to synthesize pharmacological knowledge of pharmacotherapeutic agents into a useful teaching and learning tool for nurses and patients.

1. Choose a pharmacological agent that has been on the market less than 5 years.

2. Research the literature and obtain two to three resources for current, evidence-based information related to the pharmacological agent.

3. Develop a teaching brochure and one page paper following these guidelines.

a. Brochure

  • Key/Relevant Drug Information
    • Drug Class
    • Mechanism of Action
    • Drug Administration and Dosage
    • Drug Interactions
    • Lab effects/interference
    • Special Considerations
    • Potential Side Effects/Adverse Effects/Toxicities
  • Patient Education Considerations
    • Nursing Management
    • Patient Education Considerations
    • Patient Assessment
    • Side Effects/Adverse Effects/Toxicities
    • Special considerations
  • Visual Effects/Creativity

b. One Page Paper

  • Describes intended brochure audience
  • Describes intended use of brochure
  • Includes Name, Date, Class, Reference page

c. APA Format

  • Includes no more than 3 unique errors with APA format
  • At least two (2) scholarly, primary sources from the last 5 years, excluding the textbook

d. Writing and Mechanics

  • Clearly written
  • Includes no more than three unique errors of grammar
  • Includes no more than three unique errors in writing mechanics
  • Paper is one page, excluding references and title page

Paper For Above Instructions

In recent years, the field of pharmacology has witnessed significant advancements, particularly with the development of new medications aimed at treating various health conditions. This report synthesizes pharmacological knowledge regarding a selected pharmacotherapeutic agent that has been on the market for less than five years, providing a teaching brochure and a comprehensive overview of critical patient information. The chosen pharmacological agent for this teaching plan is Breztri Aerosphere (budesonide/glycopyrrolate/formoterol), a recently approved medication for the management of chronic obstructive pulmonary disease (COPD).

Brochure Overview

Key/Relevant Drug Information

Drug Class: Breztri Aerosphere belongs to a class of medications known as inhaled corticosteroids and long-acting beta-agonists (LABAs). This combination aims to reduce inflammation in the lungs and ensure long-term bronchodilation.

Mechanism of Action: Budesonide, an inhaled corticosteroid, works by inhibiting the inflammatory response in the airways, while glycopyrrolate and formoterol act as bronchodilators that relax the muscles around the airways, improving airflow.

Drug Administration and Dosage: Breztri Aerosphere is administered via inhalation, with the recommended dosage typically being two inhalations twice daily. It is essential for patients to use the inhaler as instructed to ensure proper medication delivery.

Drug Interactions: Patients should be cautious of potential drug interactions, particularly with other medications that affect the heart rate or rhythm, as well as other inhaled medications. A thorough medication review is recommended to avoid complications.

Lab Effects/Interference: Routine monitoring of lung function through spirometry may be recommended to assess the therapeutic effectiveness of the medication. Additionally, blood glucose levels should be monitored in patients with an underlying risk of diabetes due to the steroid component of the medication.

Special Considerations: Before initiating treatment, healthcare providers should evaluate the patient for any history of hypersensitivity to inhaled medications. It is also essential to assess the patient's current medication regimen for potential interactions.

Potential Side Effects/Adverse Effects/Toxicities: Common side effects include oral thrush, cough, and headache. Serious adverse reactions may include severe respiratory infections, paradoxical bronchospasm, and cardiac dysrhythmias. Patients should be advised to seek immediate medical attention if experiencing worsening respiratory symptoms.

Patient Education Considerations

Nursing Management: Nursing management involves educating patients on the correct use of the inhaler, emphasizing the importance of adherence to the prescribed regimen and monitoring for side effects.

Patient Education Considerations: Patients should be informed about recognizing common side effects and the importance of routine follow-up appointments to monitor lung function.

Patient Assessment: Nurses should perform thorough assessments to evaluate the patient's respiratory status, including auscultation of lung sounds and monitoring respiratory rate and effort.

Side Effects/Adverse Effects/Toxicities: Patients need to be educated on potential side effects, both common and severe, so they can respond appropriately.

Special Considerations: Patients with comorbid conditions, such as hypertension and diabetes, require personalized monitoring strategies.

Visual Effects/Creativity

The brochure should be visually appealing, incorporating graphics that aid in understanding the information presented. It must be developed in accordance with a seventh-grade reading level standard to ensure accessibility for all patients.

One Page Paper

The intended audience for the brochure includes both healthcare providers and patients diagnosed with COPD. The brochure serves as a comprehensive resource outlining essential information about Breztri Aerosphere, enhancing patient understanding and adherence to treatment.

In conclusion, the synthesis of pharmacological knowledge into a teaching tool empowers nurses to effectively educate patients about their medications. Education on medication use is critical for improving health outcomes and ensuring safe therapeutic practices.

References

  • Chen, M. K., & Kim, Y. (2020). The role of inhaled medications in COPD management: Understanding the pharmacological principles. Journal of Clinical Pharmacology, 60(2), 128-138.
  • GOLD Report. (2021). Global strategy for the prevention, diagnosis, and management of COPD. Retrieved from https://goldcopd.org
  • Lehman, R., & Bando, T. (2021). Patient education strategies for chronic obstructive pulmonary disease management. Nursing Clinics of North America, 56(3), 529-549.
  • Mahler, D. A., & Wells, J. M. (2020). COPD medication therapy management and education. American Journal of Respiratory and Critical Care Medicine, 201(11), 1338-1351.
  • McCarthy, B., & Woodgate, R. (2021). Teaching tools for chronic disease education: A focus on COPD. Patient Education and Counseling, 104(10), 2293-2300.
  • National Heart, Lung, and Blood Institute. (2020). What Is COPD?. Retrieved from https://www.nhlbi.nih.gov/health-topics/copd
  • O'Byrne, P. M., & Fitzgerald, M. (2021). The evolving landscape of COPD treatment: Combination therapy as standard of care. Respiratory Medicine, 176, 106203.
  • Rabe, K. F., & Hurd, S. (2020). Global strategy for the diagnosis, management, and prevention of COPD: 2020 Report. European Respiratory Journal, 55(5), 2000326.
  • Smith, D. M., & Grabowski, L. (2020). Addressing patient barriers to adherence in COPD therapy. Chronic Respiratory Disease, 17(4), 1479973120961824.
  • U.S. Food and Drug Administration. (2021). Breztri Aerosphere prescribing information. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213688s002lbl.pdf

Related Assignments